Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer

NCT00820222 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastases, Brain

Interventions

DRUG: capecitabine
DRUG: lapatinib
DRUG: trastuzumab

Sponsor

Novartis Pharmaceuticals